Maravai Lifesciences Holdings initiates coverage with buy rating; target price $9
MRVI•TD Cowen initiated coverage of Maravai Lifesciences Holdings with a buy rating and a $9 target price.
Related News
Disney: Raymond James cuts target price to $119 from $120
DIS•
Polyrizon files for U.S. patent application to expand IP moat around intranasal drug-delivery platform
PLRZ•
Brazil economists see 2026 inflation at 5.01% in cenbank poll
EWZ•
Trinity Biotech holds annual general meeting
TRIB•
SmartStop Self Storage REIT Inc: BMO cuts target price to $37 from $38
SMA•